1. Regional Therapies for Cancer

   • T. Clark Gamblin
   • H. Richard Alexander
   • David L. Bartlett

   Regional Cancer Therapies 02 March 2013 Pages: 1053 - 1055

2. Extensive Cytoreductive Surgery for Appendiceal Carcinomatosis: Morbidity, Mortality, and Survival

   • Patrick L. Wagner
   • Frances Austin
   • Haroon A. Choudry

   Regional Cancer Therapies 02 March 2013 Pages: 1056 - 1062

   

3. Right Hemicolectomy for Mucinous Adenocarcinoma of the Appendix: Just Right or Too Much?

   • Kiran K. Turaga
   • Sam Pappas
   • T. Clark Gamblin

   Regional Cancer Therapies 02 March 2013 Pages: 1063 - 1067

   

4. Assessment of Neoadjuvant Chemotherapy on Operative Parameters and Outcome in Patients with Peritoneal Dissemination from High-Grade Appendiceal Cancer

   • Keli M. Turner
   • Nader N. Hanna
   • H. Richard Alexander Jr.

   Regional Cancer Therapies 02 March 2013 Pages: 1068 - 1073

   

5. Surveillance MR Imaging is Superior to Serum Tumor Markers for Detecting Early Tumor Recurrence in Patients with Appendiceal Cancer Treated with Surgical Cytoreduction and HIPEC

   • Russell N. Low
   • Robert M. Barone
   • Melissa J. Lee

   Regional Cancer Therapies 02 March 2013 Pages: 1074 - 1081

   

6. Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

   • Aras Emre Canda
   • Selman Sokmen
   • Mehmet Fuzun

   Regional Cancer Therapies 02 March 2013 Pages: 1082 - 1087

7. Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis from Rectal Cancer

   • Konstantinos I. Votanopoulos
   • Katrina Swett
   • Edward A. Levine

   Regional Cancer Therapies 02 March 2013 Pages: 1088 - 1092

   

8. The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

   • Marcello Deraco
   • Dario Baratti
   • Shigeki Kusamura

   Regional Cancer Therapies 02 March 2013 Pages: 1093 - 1100

   

9. Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy

   • Joshua C. Leinwand
   • Gleneara E. Bates
   • Robert N. Taub

   Gastrointestinal Oncology Open access 02 March 2013 Pages: 1101 - 1104

   

10. Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis: Role of Heat Shock Proteins and Dissecting Effects of Hyperthermia

    • Joerg O. W. Pelz
    • Malte Vetterlein
    • Martin Gasser

    Regional Cancer Therapies 02 March 2013 Pages: 1105 - 1113

    

11. Extrahepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Neuroendocrine Carcinoma

    • David Arrese
    • Megan E. McNally
    • Mark Bloomston

    Regional Cancer Therapies 02 March 2013 Pages: 1114 - 1120

    

12. Isolated Limb Infusion in a Series of Over 100 Infusions: A Single-Center Experience

    • Joyce Wong
    • Y. Ann Chen
    • Jonathan S. Zager

    Regional Cancer Therapies 02 March 2013 Pages: 1121 - 1127

    

13. Plasma Cytokine Analysis in Patients with Advanced Extremity Melanoma Undergoing Isolated Limb Infusion

    • Gina Shetty
    • Georgia M. Beasley
    • Kent J. Weinhold

    Regional Cancer Therapies 02 March 2013 Pages: 1128 - 1135

    

14. Racial Disparities in Esophageal Cancer Outcomes

    • Sha’Shonda L. Revels
    • Arden M. Morris
    • Sandra L. Wong

    Healthcare Policy and Outcomes 23 December 2012 Pages: 1136 - 1141

    

15. Association of Race and Socioeconomic Status and Outcomes of Patients with Rectal Cancer

    • James R. Nitzkorski
    • Alliric I. Willis
    • Elin R. Sigurdson

    Healthcare Policy and Outcomes 20 January 2013 Pages: 1142 - 1147

16. Do MRI Reports Contain Adequate Preoperative Staging Information for End Users to Make Appropriate Treatment Decisions for Rectal Cancer?

    • Eisar Al-Sukhni
    • David E. Messenger
    • Erin D. Kennedy

    Colorectal Cancer 10 November 2012 Pages: 1148 - 1155

17. Rectal Cancer and Teaching Hospitals: Hospital Teaching Status Affects Use of Neoadjuvant Radiation and Survival for Rectal Cancer Patients

    • David B. Stewart
    • Christopher Hollenbeak
    • Li Wang

    Colorectal Cancer 25 November 2012 Pages: 1156 - 1163

    

18. A Phase II, Randomized, Controlled Trial of Acupuncture for Reduction of Postcolectomy Ileus

    • Gary Deng
    • W. Douglas Wong
    • Barrie Cassileth

    Colorectal Cancer 28 November 2012 Pages: 1164 - 1169

    

19. Neuroendocrine Tumors of the Colon and Rectum: Prognostic Relevance and Comparative Performance of Current Staging Systems

    • Ryaz Chagpar
    • Yi-Ju Chiang
    • Y. Nancy You

    Colorectal Cancer 01 December 2012 Pages: 1170 - 1178

    

20. What is the Significance of the Circumferential Margin in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy?

    • Atthaphorn Trakarnsanga
    • Mithat Gonen
    • Martin R. Weiser

    Colorectal Cancer 18 January 2013 Pages: 1179 - 1184

    

21. Colorectal Liver Metastases: State of the Art Imaging

    • Kathryn Jane Fowler
    • David C. Linehan
    • Christine O. Menias

    Colorectal Cancer 01 November 2012 Pages: 1185 - 1193

    

22. Single HCC in Cirrhotic Patients: Liver Resection or Liver Transplantation? Long-term Outcome According to an Intention-to-treat Basis

    • Gonzalo Sapisochin
    • Lluis Castells
    • Ramón Charco

    Hepatobiliary Tumors 11 September 2012 Pages: 1194 - 1202

    

23. Short- and Long-term Outcomes after Laparoscopic and Open Hepatectomy for Hepatocellular Carcinoma: A Global Systematic Review and Meta-analysis

    • Zi Yin
    • Xinxiang Fan
    • Jie Wang

    Hepatobiliary Tumors 26 October 2012 Pages: 1203 - 1215

    

24. Effects of Genomic Changes in Hepatitis B Virus on Postoperative Recurrence and Survival in Patients with Hepatocellular Carcinoma

    • Priya Mathews
    • Danbi Lee
    • Young Joo Lee

    Hepatobiliary Tumors 27 October 2012 Pages: 1216 - 1222

    

25. Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2 cm: Reappraisal of the Staging System for Solitary Tumors

    • Junichi Shindoh
    • Andreas Andreou
    • Jean-Nicolas Vauthey

    Hepatobiliary Tumors 21 November 2012 Pages: 1223 - 1229

    

26. Novel Multimodality Treatment Sequencing for Extrahepatic (Mid and Distal) Cholangiocarcinoma

    • Kiran K. Turaga
    • Susan Tsai
    • T. Clark Gamblin

    Gastrointestinal Oncology 12 October 2012 Pages: 1230 - 1239

    

27. Palliative Resection for Advanced Gastric and Junctional Adenocarcinoma: Which Patients will Benefit from Surgery?

    • Christophe Mariette
    • Emilie Bruyère
    • the FREGAT Working Group

    Gastrointestinal Oncology 12 October 2012 Pages: 1240 - 1249

    

28. Gastrectomy for Early Gastric Cancer is Associated with Decreased Cardiovascular Mortality in Association with Postsurgical Metabolic Changes

    • Yong-ho Lee
    • Seung Jin Han
    • Hyun Chul Lee

    Gastrointestinal Oncology 18 October 2012 Pages: 1250 - 1257

    

29. Robot Versus Laparoscopic Gastrectomy for Cancer by an Experienced Surgeon: Comparisons of Surgery, Complications, and Surgical Stress

    • Myung-Han Hyun
    • Chung-Ho Lee
    • Sung-Soo Park

    Gastrointestinal Oncology 19 October 2012 Pages: 1258 - 1265

    

30. Laparoscopic Hepatic Posterior Sectionectomy: A Hand-assisted Approach

    • Paulo Herman
    • Jaime Arthur Pirola Krüger
    • Renato Micelli Lupinacci

    Gastrointestinal Oncology 16 December 2012 Pages: 1266 - 1266

31. Long-Term Outcomes in Patients with Radiation-Associated Angiosarcomas of the Breast Following Surgery and Radiotherapy for Breast Cancer

    • Keila E. Torres
    • Vinod Ravi
    • Raphael E. Pollock

    Bone and Soft Tissue Sarcomas 06 December 2012 Pages: 1267 - 1274

    

32. Should Ductal Carcinoma-in-situ (DCIS) Be Removed from the ASTRO Consensus Panel Cautionary Group for Off-protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients with DCIS Treated with APBI

    • Frank Vicini
    • Chirag Shah
    • Maureen Lyden

    Breast Oncology 29 September 2012 Pages: 1275 - 1281

    

33. Use of Preoperative Paravertebral Block Decreases Length of Stay in Patients Undergoing Mastectomy Plus Immediate Reconstruction

    • Suzanne B. Coopey
    • Michelle C. Specht
    • Katharine Fleischmann

    Breast Oncology 14 October 2012 Pages: 1282 - 1286

    

34. Factors Influencing Surgical and Adjuvant Therapy in Stage I Breast Cancer: A SEER 18 Database Analysis

    • Shayna L. Showalter
    • Surbhi Grover
    • Brian J. Czerniecki

    Breast Oncology 08 November 2012 Pages: 1287 - 1294

    

35. Dosimetric Feasibility and Acute Toxicity in a Prospective Trial of Ultrashort-Course Accelerated Partial Breast Irradiation (APBI) Using a Multi-Lumen Balloon Brachytherapy Device

    • A. J. Khan
    • F. A. Vicini
    • D. Arthur

    Breast Oncology 13 November 2012 Pages: 1295 - 1301

36. Blurry Boundaries: Do Epithelial Borderline Lesions of the Breast and Ductal Carcinoma In Situ Have Similar Rates of Subsequent Invasive Cancer?

    • Daniel X. Choi
    • Anne A. Eaton
    • Kimberly J. Van Zee

    Breast Oncology 19 November 2012 Pages: 1302 - 1310

    

37. Thoracoscopic Internal Mammary Lymph Node Dissection: A Video Demonstration

    • Hao Long
    • Dong-Rong Situ
    • Yan Zheng

    Breast Oncology 04 December 2012 Pages: 1311 - 1312

38. Radiation Therapy Following Postmastectomy Reconstruction: A Systematic Review

    • Chirag Shah
    • Neilendu Kundu
    • Frank Vicini

    Breast Oncology 08 October 2012 Pages: 1313 - 1322

    

39. Lumpectomy Closure Technique Does Not Affect Dosimetry in Patients Undergoing External-Beam-Based Accelerated Partial Breast Irradiation

    • Talha Shaikh
    • Venkat Narra
    • Atif J. Khan

    Radiation Oncology 11 December 2012 Pages: 1323 - 1328

40. Evaluating the Prognostic Factors Associated with Cancer-specific Survival of Differentiated Thyroid Carcinoma Presenting with Distant Metastasis

    • Brian Hung-Hin Lang
    • Kai Pun Wong
    • Chung-Yau Lo

    Endocrine Tumors Open access 28 October 2012 Pages: 1329 - 1335

    

41. Toxic Nodular Goiter and Cancer: A Compelling Case for Thyroidectomy

    • J. Joshua Smith
    • Xi Chen
    • Carmen C. Solorzano

    Endocrine Tumors 30 October 2012 Pages: 1336 - 1340

    

42. Association of Thyroid, Breast and Renal Cell Cancer: A Population-based Study of the Prevalence of Second Malignancies

    • Victoria L. Van Fossen
    • Scott M. Wilhelm
    • Christopher R. McHenry

    Endocrine Tumors 21 December 2012 Pages: 1341 - 1347

    

43. Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation

    • Christina Fotopoulou
    • Rongyu Zang
    • Jalid Sehouli

    Gynecologic Oncology 02 October 2012 Pages: 1348 - 1354

    

44. Analgesic and Antiemetic Requirements After Minimally Invasive Surgery for Early Cervical Cancer: A Comparison Between Laparoscopy and Robotic Surgery

    • Pamela T. Soliman
    • Ginger Langley
    • Pedro T. Ramirez

    Gynecologic Oncology 05 October 2012 Pages: 1355 - 1359

45. A Collision of Diseases: Chronic Lymphocytic Leukemia Discovered During Lymph Node Biopsy for Melanoma

    • Jeffrey M. Farma
    • Jonathan S. Zager
    • Vernon K. Sondak

    Melanomas 20 November 2012 Pages: 1360 - 1364

    

46. Merkel Cell Carcinoma: 30-Year Experience from a Single Institution

    • Juan A. Santamaria-Barria
    • Genevieve M. Boland
    • James C. Cusack Jr.

    Melanomas 01 December 2012 Pages: 1365 - 1373

    

47. Incidence and Predictive Factors for Pulmonary Metastases After Curative Resection of Colon Cancer

    • Kazuhiro Watanabe
    • Norio Saito
    • Yusuke Nishizawa

    Thoracic Oncology 30 November 2012 Pages: 1374 - 1380

    

48. KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy

    • Ji-lin Guan
    • Wen-zhao Zhong
    • Yi-long Wu

    Thoracic Oncology 04 December 2012 Pages: 1381 - 1388

    

49. External Validation of Extranodal Extension and Lymph Node Density as Predictors of Survival in Node-positive Bladder Cancer after Radical Cystectomy

    • Alexandra Masson-Lecomte
    • Dimitri Vordos
    • Laurent Salomon

    Urologic Oncology 04 December 2012 Pages: 1389 - 1394

    

50. The rs6983267 SNP Is Associated with MYC Transcription Efficiency, Which Promotes Progression and Worsens Prognosis of Colorectal Cancer

    • Yasushi Takatsuno
    • Koshi Mimori
    • Masaki Mori

    Translational Research and Biomarkers 14 September 2012 Pages: 1395 - 1402